HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction
Authors
James Moon (ORCID: https://orcid.org/0000-0001-8071-1491)
Arjun K. Ghosh (ORCID: https://orcid.org/0000-0003-4992-2412)
Peter Kellman (ORCID: https://orcid.org/0000-0002-9875-6070)
Mark Westwood (ORCID: https://orcid.org/0000-0001-6846-8134)
Muhummad Sohaib Nazir (ORCID: https://orcid.org/0000-0003-2749-1033)
Benjamin Dowsing (ORCID: https://orcid.org/0000-0002-8877-0629)
María Sol Andrés (ORCID: https://orcid.org/0000-0002-9554-2026)
Charlotte Manisty (ORCID: https://orcid.org/0000-0003-0245-7090)
John Malcolm Walker (ORCID: https://orcid.org/0000-0002-8559-7218)
Alexander Richard Lyon (ORCID: https://orcid.org/0000-0001-8026-840X)
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Funders
National Institute for Health and Care Research
British Heart Foundation
University College London
Barts Health NHS Trust
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction
James Moon, Arjun K. Ghosh, Peter Kellman, Mark Westwood et al.
Journal
BMJ Open
Topics
Chemotherapy-induced cardiotoxicity and mitigation
article
HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction
James Moon, Arjun K. Ghosh, Peter Kellman, Mark Westwood, Muhummad Sohaib Nazir, Benjamin Dowsing, María Sol Andrés, Charlotte Manisty, John Malcolm Walker, Alexander Richard Lyon, Jessica Artico, Hakim‐Moulay Dehbi, Daniel Chen, Rebecca Roylance, Tom Crake, Peter Schmid, Robin Chung, Joanna Pedra, Orla Worn
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
St Bartholomew's Hospital (GB), Imperial College Healthcare NHS Trust (GB), Queen Mary University of London (GB), King's College London (GB), Barts Health NHS Trust (GB), Harefield Hospital (GB), Royal Brompton Hospital (GB), National Heart, Lung, and Blood Institute (US), Whittington Health NHS Trust (GB), University College London (GB)
Funders
National Institute for Health and Care Research, British Heart Foundation, University College London, Barts Health NHS Trust
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 96%
Topics
Chemotherapy-induced cardiotoxicity and mitigation